TOKUSHIMA, Japan--(BUSINESS WIRE)--We are excited to share our latest development status. We are pleased to announce that as a result of consultation with the PMDA on December 3rd, 2024, the Phase ...
TOKUSHIMA, Japan--(BUSINESS WIRE)--Delta-Fly Pharma, Inc. (TOKYO: 4598) announces that patients have registered for clinical studies in the USA on anti-cancer drug candidates DFP-10917 and DFP-14927.
TheFinancial Planning Association(FPA) will continue to allow training providers to apply for exemptions in regards to Diploma of Financial Planning (DFP) equivalent courses for a further three years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback